MR编号 | CZ/V/0141/001 |
---|
药品名称 | BOVALTO Respi Intranasal |
---|
活性成分 | - Bovine parainfluenza 3 virus 7.0 log10 TCID50/d
- bovine respiratory syncytial virus 6.0 log10 TCID50/d
|
---|
剂型 | Lyophilisate and Solvent |
---|
上市许可持有人 | Boehringer Ingelheim Animal Health France SCS
29 Avenue Tony Garnier
Lyon, 69007
France |
---|
参考成员国 - 产品名称 | Czechia (CZ) BOVALTO RESPI INTRANASAL, nosní sprej, lyofilizát a rozpouštědlo pro suspenzi |
---|
互认成员国 - 产品名称 | - Germany (DE)
- Denmark (DK)
- Belgium (BE)
Bovalto Respi Intranasal - Netherlands (NL)
- Luxembourg (LU)
- United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Austria (AT)
- France (FR)
- Spain (ES)
BOVALTO RESPI INTRANASAL - Portugal (PT)
- Italy (IT)
- Greece (GR)
- Sweden (SE)
- Norway (NO)
- Poland (PL)
- Romania (RO)
|
---|
许可日期 | 2017/12/20 |
---|
最近更新日期 | 2023/06/24 |
---|
药物ATC编码 | - QI02AD07 bovine respiratory syncytial virus + bovine parainfluenza virus
|
---|
申请类型 | - TypeLevel1:food
- TypeLevel2:Immunological
- TypeLevel3:Full dossier - art 12.3 Dir 2001/82/EC
- TypeLevel4:[not specified]
- TypeLevel5:[not specified]
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|